-
-
-
-
-
-
-
ARS Pharmaceuticals, Inc. (SPRY) Misses Q3 EPS by 6c
-
-
-
-
-
-
-
ARS Pharmaceuticals, Inc. (SPRY) Misses Q1 EPS by 1c
-
-
-
-
-
-
-
ARS Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates
-
-
-
-
-
-
-
ARS Pharmaceuticals Highlights neffy Regulatory Progress and Reports First Quarter 2024 Financial Results
-
-
-
-
-
-
-
ARS Pharmaceuticals Highlights Progress and Reports Fourth Quarter and Full Year 2022 Financial Results
-
1,197,507 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

